New London IPOs hit 28-year low amid AstraZeneca exit concerns

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca Plc’s chief executive officer wants to move the company’s listing to the US. With companies going where liquidity is abundant, a steady drip of firms being taken private,…
|
||||
|
||||
You Might Like |